Sharma, P., & Allison, J. P. (2015). Immune checkpoint targeting in cancer therapy: Toward combination strategies with curative potential. Cell, 161(2), 205–214.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Waldman, A. D., Fritz, J. M., & Lenardo, M. J. (2020). A guide to cancer immunotherapy: From T cell basic science to clinical practice. Nature Reviews Immunology, 20(11), 651–668.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Powles, T., Durán, I., van der Heijden, M. S., Loriot, Y., Vogelzang, N. J., De Giorgi, U., Oudard, S., Retz, M. M., Castellano, D., Bamias, A., et al. (2018). Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): A multicentre, open-label, phase 3 randomised controlled trial. The Lancet, 391(10122), 748–757.

Article  CAS  Google Scholar 

Prasad, V., Haslam, A., & Olivier, T. (2024). Updated estimates of eligibility and response: Immune checkpoint inhibitors. Journal of Clinical Oncology, 42(16), e14613–e14613.

Article  Google Scholar 

Emens, L. A., Romero, P. J., Anderson, A. C., Bruno, T. C., Capitini, C. M., Collyar, D., Gulley, J. L., Hwu, P., Posey, A. D., Jr., Silk, A. W., et al. (2024). Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision. Journal for Immunotherapy of Cancer, 12, 6.

Article  Google Scholar 

Jayathilaka B, Mian F, Franchini F, Au-Yeung G, M IJ: Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review. Br J Cancer 2024.

Conroy, M., & Naidoo, J. (2022). Immune-related adverse events and the balancing act of immunotherapy. Nature Communications, 13(1), 392.

Article  CAS  PubMed  PubMed Central  Google Scholar 

von Itzstein, M. S., Gerber, D. E., Bermas, B. L., & Meara, A. (2024). Acknowledging and addressing real-world challenges to treating immune-related adverse events. Journal of Immunotherapy Cancer, 12, 7.

Google Scholar 

Marusyk, A., Janiszewska, M., & Polyak, K. (2020). Intratumor heterogeneity: the rosetta stone of therapy resistance. Cancer Cell, 37(4), 471–484.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lobo, N., Brooks, N. A., Zlotta, A. R., Cirillo, J. D., Boorjian, S., Black, P. C., Meeks, J. J., Bivalacqua, T. J., Gontero, P., Steinberg, G. D., et al. (2021). 100 years of Bacillus Calmette-Guérin immunotherapy: from cattle to COVID-19. Nature Reviews Urology, 18(10), 611–622.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cappell, K. M., & Kochenderfer, J. N. (2023). Long-term outcomes following CAR T cell therapy: What we know so far. Nature Reviews Clinical Oncology, 20(6), 359–371.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kalbasi, A., & Ribas, A. (2020). Tumour-intrinsic resistance to immune checkpoint blockade. Nature Reviews Immunology, 20(1), 25–39.

Article  CAS  PubMed  Google Scholar 

Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011). Photodynamic therapy of cancer: An update. CA Cancer JClin, 61(4), 250–281.

Article  Google Scholar 

Castano, A. P., Mroz, P., & Hamblin, M. R. (2006). Photodynamic therapy and anti-tumour immunity. NatRevCancer, 6(7), 535–545.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Canti, G., Lattuada, D., Nicolin, A., Taroni, P., Valentini, G., & Cubeddu, R. (1994). Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light. Anti-Cancer Drugs, 5(4), 443–447.

Article  CAS  PubMed  Google Scholar 

Selbo PK, Korbelik M: Topical collection on photodynamic therapy-enhanced antitumour immunity. Photochem Photobiol Sci 2024

Korbelik, M., Krosl, G., Krosl, J., & Dougherty, G. J. (1996). The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Research, 56(24), 5647–5652.

CAS  PubMed  Google Scholar 

Gomer, C. J., Ryter, S. W., Ferrario, A., Rucker, N., Wong, S., & Fisher, A. M. (1996). Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins. Cancer Research, 56(10), 2355–2360.

CAS  PubMed  Google Scholar 

Korbelik, M., & Cecic, I. (1999). Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. Cancer Letters, 137(1), 91–98.

Article  CAS  PubMed  Google Scholar 

Krosl, G., Korbelik, M., & Dougherty, G. J. (1995). Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. British Journal of Cancer, 71(3), 549–555.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gollnick, S. O., Liu, X., Owczarczak, B., Musser, D. A., & Henderson, B. W. (1997). Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Research, 57(18), 3904–3909.

CAS  PubMed  Google Scholar 

Korbelik, M., Zhang, W., & Merchant, S. (2011). Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: Surface expression of calreticulin and high-mobility group box-1 release. Cancer Immunology, Immunotherapy, 60(10), 1431–1437.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Korbelik, M. (2018). Role of cell stress signaling networks in cancer cell death and antitumor immune response following proteotoxic injury inflicted by photodynamic therapy. Lasers in Surgery and Medicine, 50(5), 491–498.

Article  PubMed  Google Scholar 

Garg, A. D., Krysko, D. V., Vandenabeele, P., & Agostinis, P. (2011). DAMPs and PDT-mediated photo-oxidative stress: Exploring the unknown. Photochemical & Photobiological Sciences, 10(5), 670–680.

Article  CAS  Google Scholar 

Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012). Immunogenic cell death and DAMPs in cancer therapy. Nature Reviews Cancer, 12(12), 860–875.

Article  CAS  PubMed  Google Scholar 

Gomes-da-Silva, L. C., Zhao, L., Bezu, L., Zhou, H., Sauvat, A., Liu, P., Durand, S., Leduc, M., Souquere, S., Loos, F., et al. (2018). Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus. EMBO Journal, 37, 13.

Article  Google Scholar 

Beltrán Hernández, I., Yu, Y., Ossendorp, F., Korbelik, M., & Oliveira, S. (2020). Preclinical and clinical evidence of immune responses triggered in oncologic photodynamic therapy: clinical recommendations. Journal of Clinical Medicine, 9, 2.

Article  Google Scholar 

Chen, B., Pogue, B. W., Hoopes, P. J., & Hasan, T. (2005). Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy. IntJRadiatOncolBiolPhys, 61(4), 1216–1226.

CAS  Google Scholar 

Kabingu, E., Oseroff, A. R., Wilding, G. E., & Gollnick, S. O. (2009). Enhanced systemic immune reactivity to a Basal cell carcinoma associated antigen following photodynamic therapy. Clinical Cancer Research, 15(13), 4460–4466.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Piette, J. (2015). Signalling pathway activation by photodynamic therapy: NF-κB at the crossroad between oncology and immunology. Photochemical & Photobiological Sciences, 14(8), 1510–1517.

Article  CAS  Google Scholar 

Hendren, S. K., Hahn, S. M., Spitz, F. R., Bauer, T. W., Rubin, S. C., Zhu, T., Glatstein, E., & Fraker, D. L. (2001). Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Annals of Surgical Oncology, 8(1), 65–71.

Article  CAS  PubMed  Google Scholar 

Thong, P. S., Ong, K. W., Goh, N. S., Kho, K. W., Manivasager, V., Bhuvaneswari, R., Olivo, M., & Soo, K. C. (2007). Photodynamic-therapy-activated immune response against distant untreated tumours in recurrent angiosarcoma. The lancet Oncology, 8(10), 950–952.

Article  CAS  PubMed  Google Scholar 

Agarwal, M. L., Clay, M. E., Harvey, E. J., Evans, H. H., Antunez, A. R., & Oleinick, N. L. (1991). Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Research, 51(21), 5993–5996.

CAS  PubMed  Google Scholar 

Buytaert, E., Callewaert, G., Hendrickx, N., Scorrano, L., Hartmann, D., Missiaen, L., Vandenheede, J. R., Heirman, I., Grooten, J., & Agostinis, P. (2006). Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy. The FASEB Journal, 20(6), 756–758.